These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 92386)

  • 41. Refsum's disease: management by diet and plasmapheresis.
    Hungerbühler JP; Meier C; Rousselle L; Quadri P; Bogousslavsky J
    Eur Neurol; 1985; 24(3):153-9. PubMed ID: 2581787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atypical phenotype of Refsum's disease: clinical, biochemical, neurophysiological and pathological study.
    Dotti MT; Rossi A; Rizzuto N; Hayek G; Bardelli N; Bardelli AM; Federico A
    Eur Neurol; 1985; 24(2):85-93. PubMed ID: 2579819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 2,6-Dimethyloctanedioic acid--a metabolite of phytanic acid in Refsum's disease.
    Greter J; Lindstedt S; Steen G
    Clin Chem; 1983 Mar; 29(3):434-7. PubMed ID: 6186413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The fatty acid composition of skin and plasma lipids in Refsum's disease.
    Reynolds DJ; Marks R; Davies MG; Dykes PJ
    Clin Chim Acta; 1978 Dec; 90(2):171-7. PubMed ID: 82497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peroxisomes in fibroblasts from skin of Refsum's disease patients.
    Beard ME; Sapirstein V; Kolodny EH; Holtzman E
    J Histochem Cytochem; 1985 May; 33(5):480-4. PubMed ID: 2580885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [REFSUM'S SYNDROME (HEREDOPATHIA ATACTICA POLYNEURITIFORMIS): CONGENITAL DISORDER OF LIPID METABOLISM WITH STORAGE OF 3,7,11,15-TETRAMETHYL-HEXADECANOIC ACID].
    RICHTERICH R; KAHLKE W; VAN MECHELEN ; ROSSI E
    Klin Wochenschr; 1963 Aug; 41():800-1. PubMed ID: 14045591
    [No Abstract]   [Full Text] [Related]  

  • 47. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
    Wanders RJ; Komen JC
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fatty acid composition of tissues in Refsum's disease (herodopathia atactica polyneuritiformis). Estimation of total phytanic acid accumulation.
    Malmendier CL; Jonniaux G; Voet W; Van Den Bergen CJ
    Biomedicine; 1974 Nov; 20(6):398-407. PubMed ID: 4141904
    [No Abstract]   [Full Text] [Related]  

  • 49. Human phytanoyl-CoA hydroxylase: resolution of the gene structure and the molecular basis of Refsum's disease.
    Jansen GA; Hogenhout EM; Ferdinandusse S; Waterham HR; Ofman R; Jakobs C; Skjeldal OH; Wanders RJ
    Hum Mol Genet; 2000 May; 9(8):1195-200. PubMed ID: 10767344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Refsum's disease and metabolism of phytanic acid.
    Stokke O; Refsum S
    Lancet; 1982 Apr; 1(8277):906-7. PubMed ID: 6175864
    [No Abstract]   [Full Text] [Related]  

  • 51. In vivo study of phytanic acid alpha-oxidation in classic Refsum's disease and chondrodysplasia punctata.
    ten Brink HJ; Schor DS; Kok RM; Stellaard F; Kneer J; Poll-The BT; Saudubray JM; Jakobs C
    Pediatr Res; 1992 Nov; 32(5):566-70. PubMed ID: 1282700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The congenital triangular deformity of the tubular bones of hand and foot.
    Jaeger M; Refior HJ
    Clin Orthop Relat Res; 1971; 81():139-50. PubMed ID: 4332222
    [No Abstract]   [Full Text] [Related]  

  • 53. [NEURO-OCULO-CUTANEOUS MANIFESTATIONS DURING REFSUM'S DISEASE].
    ARDOUIN M; PECKER J; PETIT J; FEUVRIER YM
    Bull Mem Soc Fr Ophtalmol; 1963; 76():137-9. PubMed ID: 14174216
    [No Abstract]   [Full Text] [Related]  

  • 54. [Heredopathia atactica polyneuritiformis: phytanic acid storage disease (Refsum's syndrome). Effect of diet therapy on retinal and cochlear changes].
    Refsum S
    Neurol Neurochir Pol; 1984; 18(1):1-4. PubMed ID: 6203044
    [No Abstract]   [Full Text] [Related]  

  • 55. Refsum's disease: defective oxidation of phytanic acid in tissue cultures derived from homozygotes and heterozygotes.
    Herndon JH; Steinberg D; Uhlendorf BW
    N Engl J Med; 1969 Nov; 281(19):1034-8. PubMed ID: 4188238
    [No Abstract]   [Full Text] [Related]  

  • 56. [Heredopathia atactica polyneuritiformis. Hexadecanoic acid storage disease (Refsum's disease). Definition, treatment and pathogenesis. A short review].
    Refsum S
    Psychiatr Neurol Med Psychol Beih; 1977; 22-23():11-8. PubMed ID: 95656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Refsum's disease].
    Rougier J
    Arch Ophtalmol Rev Gen Ophtalmol; 1970 Oct; 30(10):665-72. PubMed ID: 4099091
    [No Abstract]   [Full Text] [Related]  

  • 58. Metabolism of phytanic acid in Refsum's disease.
    Billimoria JD; Clemens ME; Gibberd FB; Whitelaw MN
    Lancet; 1982 Jan; 1(8265):194-6. PubMed ID: 6172683
    [No Abstract]   [Full Text] [Related]  

  • 59. [A rare case of multiple sesamoid bones in the hands and feet].
    Borsoni GO
    Radiol Med; 1990 Apr; 79(4):388-90. PubMed ID: 2377758
    [No Abstract]   [Full Text] [Related]  

  • 60. Infantile Refsum's disease: a peroxisomal storage disorder?
    Manson JI; Pollard AC; Poulos A; Carter RF
    Clin Exp Neurol; 1985; 21():283-7. PubMed ID: 2436838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.